EP3509584

GLUCOCORTICOID RECEPTOR MODULATORS TO TREAT PANCREATIC CANCER

  • Status:
    EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi
  • EP appl. date:
    8.9.2017
  • EP published:
    13.5.2026
  • EP application number:
    17849673.3
  • Max expiry date:
    7.9.2037
  • Expiry date:
    12.9.2026
  • Title in English:
    GLUCOCORTICOID RECEPTOR MODULATORS TO TREAT PANCREATIC CANCER
  • Language of the patent:
    English

Timeline

Today
8.9.2017EP application
13.5.2026EP Publication
12.9.2026Expires

Owner

  • Name:
    Corcept Therapeutics Incorporated
  • Address:
    101 Redwood Shores Parkway, Redwood City, CA 94065, US

Inventor

  • Name:
    HUNT, Hazel
  • Address:
    Menlo Park, California 94025, US
  • Name:
    BLOCK, Thaddeus S.
  • Address:
    Menlo Park, California 94025, US

Priority

  • Number:
    201662385590 P
  • Date:
    9.9.2016
  • Country:
    US

Classification

  • Categories:
    A61K 31/337, A61P 35/00, A61K 45/06, A61K 33/24, A61K 31/473, A61K 31/4745, A61K 31/7068, A61K 31/513, A61P 1/18, A61K 33/243, A61P 43/00

Upload documents